What does B & G DOCTORS ASSOCIATES do?

B & G DOCTORS ASSOCIATES is a healthcare practice in Oosterzele. Private Limited, started on 2 November 2009, 1 establishment.

What is the address of B & G DOCTORS ASSOCIATES?

The registered office of B & G DOCTORS ASSOCIATES is located at Kwaadbeek 64, 9860 Oosterzele.

Is B & G DOCTORS ASSOCIATES still active?

Yes. According to the CBE (29 October 2026) B & G DOCTORS ASSOCIATES is active, legal situation “Normale toestand”, started on 2 November 2009.

Is B & G DOCTORS ASSOCIATES registered on Peppol?

Yes, B & G DOCTORS ASSOCIATES is registered on the Peppol network with ID 0208:0820340777.

What is the enterprise number of B & G DOCTORS ASSOCIATES?

The enterprise number of B & G DOCTORS ASSOCIATES is BE0820340777.

When was B & G DOCTORS ASSOCIATES founded?

B & G DOCTORS ASSOCIATES was founded on 2 November 2009.

Who are the directors of B & G DOCTORS ASSOCIATES?

According to the 2025 annual accounts, the directors of B & G DOCTORS ASSOCIATES are: Véronique Grulois, Ian Buysschaert.

Is B & G DOCTORS ASSOCIATES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 2 November 2009; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did B & G DOCTORS ASSOCIATES make in 2025?

B & G DOCTORS ASSOCIATES posted a profit after taxes of € 821,784 in financial year 2025.

What is the revenue of B & G DOCTORS ASSOCIATES?

As a small company, B & G DOCTORS ASSOCIATES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,207,359.

How many employees does B & G DOCTORS ASSOCIATES have?

According to the 2025 annual accounts, B & G DOCTORS ASSOCIATES has 0 full-time equivalents (FTE).

B & G DOCTORS ASSOCIATES (Private Limited) - Oosterzele

Dossier B & G DOCTORS ASSOCIATES, printed on 29 October 2026 from databakkes.be/en/0820340777/b-g-doctors-associates. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

B & G DOCTORS ASSOCIATES from Oosterzele, company number BE0820340777, closed financial year 2025 with a result of € 821,784 after tax. For that financial year B & G DOCTORS ASSOCIATES recorded a gross margin of € 1.2 million and equity of € 2.3 million. Compared with financial year 2024, the result moved from € 631,534 to € 821,784. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Growing

€ 2.3 million

▲ 17% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 821,784

▲ 30% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 833,722

▲ 117% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 486,451 paid out

59 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 170,968

▼ 21% vs 2024

Of which on lease € 131,219.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 73,578

▼ 21% vs 2024

€ 20,067 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 2,266

▼ 59% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 246,328

▲ 169% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 656,798 Gross margin 2022: € 656,798 First fiscal year in the series	€ 768,301 Gross margin 2023: € 768,301 ▲ 17% vs 2022 (€ 656,798) Favourable step	€ 994,730 Gross margin 2024: € 994,730 ▲ 29% vs 2023 (€ 768,301) Favourable step	€ 1,207,359 Gross margin 2025: € 1,207,359 ▲ 21% vs 2024 (€ 994,730) Favourable step	▲ 21%
Profit after taxes	€ 383,161 Profit after taxes 2022: € 383,161 First fiscal year in the series	€ 455,761 Profit after taxes 2023: € 455,761 ▲ 19% vs 2022 (€ 383,161) Favourable step	€ 631,534 Profit after taxes 2024: € 631,534 ▲ 39% vs 2023 (€ 455,761) Favourable step	€ 821,784 Profit after taxes 2025: € 821,784 ▲ 30% vs 2024 (€ 631,534) Favourable step	▲ 30%
Equity	€ 1,356,515 Equity 2022: € 1,356,515 First fiscal year in the series	€ 1,522,593 Equity 2023: € 1,522,593 ▲ 12% vs 2022 (€ 1,356,515) Favourable step	€ 1,956,906 Equity 2024: € 1,956,906 ▲ 29% vs 2023 (€ 1,522,593) Favourable step	€ 2,292,239 Equity 2025: € 2,292,239 ▲ 17% vs 2024 (€ 1,956,906) Favourable step	▲ 17%
Total debts	€ 495,591 Total debts 2022: € 495,591 First fiscal year in the series	€ 605,632 Total debts 2023: € 605,632 ▲ 22% vs 2022 (€ 495,591) Unfavourable step	€ 387,851 Total debts 2024: € 387,851 ▼ 36% vs 2023 (€ 605,632) Favourable step	€ 341,311 Total debts 2025: € 341,311 ▼ 12% vs 2024 (€ 387,851) Favourable step	▼ 12%
Cash	€ 860,591 Cash 2022: € 860,591 First fiscal year in the series	€ 691,084 Cash 2023: € 691,084 ▼ 20% vs 2022 (€ 860,591) Unfavourable step	€ 383,672 Cash 2024: € 383,672 ▼ 44% vs 2023 (€ 691,084) Unfavourable step	€ 833,722 Cash 2025: € 833,722 ▲ 117% vs 2024 (€ 383,672) Favourable step	▲ 117%
Land & buildings	€ 269,764 Land & buildings 2022: € 269,764 First fiscal year in the series	€ 257,200 Land & buildings 2023: € 257,200 ▼ 5% vs 2022 (€ 269,764) Unchanged	€ 264,762 Land & buildings 2024: € 264,762 ▲ 3% vs 2023 (€ 257,200) Unchanged	€ 235,063 Land & buildings 2025: € 235,063 ▼ 11% vs 2024 (€ 264,762) Unchanged	▼ 11%
Retained profit	€ 1,350,315 Retained profit 2022: € 1,350,315 First fiscal year in the series	€ 1,522,593 Retained profit 2023: € 1,522,593 ▲ 13% vs 2022 (€ 1,350,315) Favourable step	€ 1,956,906 Retained profit 2024: € 1,956,906 ▲ 29% vs 2023 (€ 1,522,593) Favourable step	€ 2,292,239 Retained profit 2025: € 2,292,239 ▲ 17% vs 2024 (€ 1,956,906) Favourable step	▲ 17%
Dividend	€ 119,163 Dividend 2022: € 119,163 First fiscal year in the series	€ 283,482 Dividend 2023: € 283,482 ▲ 138% vs 2022 (€ 119,163) Unchanged	€ 197,220 Dividend 2024: € 197,220 ▼ 30% vs 2023 (€ 283,482) Unchanged	€ 486,451 Dividend 2025: € 486,451 ▲ 147% vs 2024 (€ 197,220) Unchanged	▲ 147%
Bank debt	€ 326,270 Bank debt 2022: € 326,270 First fiscal year in the series	€ 293,754 Bank debt 2023: € 293,754 ▼ 10% vs 2022 (€ 326,270) Favourable step	€ 93,645 Bank debt 2024: € 93,645 ▼ 68% vs 2023 (€ 293,754) Favourable step	€ 73,578 Bank debt 2025: € 73,578 ▼ 21% vs 2024 (€ 93,645) Favourable step	▼ 21%
Balance sheet total	€ 1,852,106 Balance sheet total 2022: € 1,852,106 First fiscal year in the series	€ 2,128,225 Balance sheet total 2023: € 2,128,225 ▲ 15% vs 2022 (€ 1,852,106) Unchanged	€ 2,344,757 Balance sheet total 2024: € 2,344,757 ▲ 10% vs 2023 (€ 2,128,225) Unchanged	€ 2,633,550 Balance sheet total 2025: € 2,633,550 ▲ 12% vs 2024 (€ 2,344,757) Unchanged	▲ 12%

Key figures of B & G DOCTORS ASSOCIATES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to B & G DOCTORS ASSOCIATES?

What happened at B & G DOCTORS ASSOCIATES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: profit of € 821,784 (▲ 30% vs 2024). Source: NBB ↗
2022 Véronique Grulois became a director. NBB
2022 Ian Buysschaert became a director. NBB
Nov 2, 2009 New establishment in Oosterzele. KBO
Nov 2, 2009 Start of the company according to the CBE. KBO

In short

From € 383,161 profit in 2022 to € 821,784 profit in 2025.

Paid € 1.1 million in corporate taxes since 2022.

Best year ever: 2025, with € 821,784 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Véronique Grulois Ian Buysschaert

Clinique Saint-Jean

B & G DOCTORS ASSOCIATES

CATHLAB

AMPLO

Behind B & G DOCTORS ASSOCIATES are Véronique Grulois and Ian Buysschaert. Véronique Grulois is also behind Clinique Saint-Jean. Ian Buysschaert is also behind CATHLAB and AMPLO.

Directors

According to the 2025 annual accounts

Véronique Grulois

Director

Also active at: Clinique Saint-Jean

since 2022

Ian Buysschaert

Director

Also active at: CATHLAB, AMPLO

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Kwaadbeek 64

9860 Oosterzele

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

AMPLO same network

€ -67 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0820.340.777

VAT number

BE 0820.340.777

Registered office

Kwaadbeek 64, 9860 Oosterzele

Names & denominations

B & G DOCTORS ASSOCIATES

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

2 November 2009

Peppol

Active · Active since 24 Apr 2025

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

B & G DOCTORS ASSOCIATES

Financials

What happened to B & G DOCTORS ASSOCIATES?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions